Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Cerebrovascular adaptations to cocaine-induced transient ischemic attacks in the rodent brain
Jiang You, … , Congwu Du, Yingtian Pan
Jiang You, … , Congwu Du, Yingtian Pan
Published March 9, 2017
Citation Information: JCI Insight. 2017;2(5):e90809. https://doi.org/10.1172/jci.insight.90809.
View: Text | PDF
Research Article Angiogenesis Vascular biology

Cerebrovascular adaptations to cocaine-induced transient ischemic attacks in the rodent brain

  • Text
  • PDF
Abstract

Occurrence of transient ischemic attacks (TIA) and cerebral strokes is a recognized risk associated with cocaine abuse. Here, we use a rodent model along with optical imaging to study cocaine-induced TIA and the associated dynamic changes in cerebral blood flow velocity (CBFv) and cerebrovasculature. We show that chronic cocaine exposure in mice resulted in marked cortical hypoperfusion, in significant arterial and venous vasoconstriction, and in a sensitized vascular response to an acute cocaine injection. Starting after 10 days of exposure, an acute cocaine challenge to these mice resulted in a TIA, which presented as hemiparalysis and was associated with an abrupt exacerbation of CBFv. The severity of the TIA correlated with the decreases in cortical CBFv such that the greater the decreases in flow, the longer the TIA duration. The severity of TIA peaked around 17–22 days of cocaine exposure and decreased thereafter in parallel to a reorganization of CBFv from superficial to deep cortical layers, along with an increase in vessel density into these layers. Here, we document for the first time to our knowledge evidence of a TIA in an animal model of chronic cocaine exposure that was associated with profound decreases in CBFv, and we revealed that while the severity of the TIA initially increased with repeated exposures, it subsequently improved in parallel to an increase in the vessel density. This suggests that strategies to accelerate cerebrovascular recovery might be therapeutically beneficial in cocaine abusers.

Authors

Jiang You, Nora D. Volkow, Kicheon Park, Qiujia Zhang, Kevin Clare, Congwu Du, Yingtian Pan

×

Figure 2

Representative μODT images of the sensorimotor cortex with behavioral images between a control mouse and a TIA mouse after chronic cocaine exposures, and temporal relationship between the TIA incidences and the cortical CBF changes of animals.

Options: View larger image (or click on image) Download as PowerPoint
Representative μODT images of the sensorimotor cortex with behavioral im...
(A) μODT images of left and right sensorimotor cortices of a control mouse and behavior recording of normal limb locomotion after saline injection. (B) μODT images of left and right sensorimotor cortices of chronic cocaine mouse and behavior recording of hemiparalysed limb after acute cocaine (35 mg/kg, i.p.). Scale bars: 200 μm. (C) Time courses of TIA incidences (n = 7) and the CBFv decreases in arteries and veins of the brains (n = 5), indicating that ΔCBFv decreases precede the TIA. (D) Correlation analysis between ΔCBFv (%) and the maximal duration of TIAs, indicating that TIA were associated with the CBF decrease in the cortical vessels (r = 0.82 for arteries and 0.77 for veins, tested by linear regression).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts